Proteomics

Dataset Information

0

MudPIT analyses of the proteins co-purified with components of the LSD1 (KDM1A) transcriptional repressor complex and the non-canonical BAF complex, immuno-precipitated from MKL-1 and WaGa MCC cell lines


ABSTRACT: Protein Complexes Purification: Immunoprecipitations were performed with antibodies to LSD1 (2139; Cell signaling technology), INSM1 Mouse (SC-271408, Santa Cruz Biotechnology), RCOR2 (23969-1-AP; Proteintech Group), BRD9 (61537; Active Motif Rabbit), and normal Rabbit IgG (2729; Cell signaling technology). MKL-1 or WaGa suspension cells were harvested in EBC lysis buffer. INSM1 was also immunopurified from MKL-1 cells treated with the GSK-LSD1 inhibitor for 3 days. For all IPs, clarified cell extract (100-300 mg) was incubated overnight at 4oC with 20ug antibodies crosslinked to 30 mg protein G agarose beads by dimethyl pimelimidate. Beads were washed with high salt buffer 5x, eluted with 0.2 M glycine pH 3 and neutralized with 1 M Tris pH 8.0. Proteins were precipitated with 1/5 TCA overnight at 4oC and washed 2x with cold acetone. Multidimensional Protein Identification Technology: TCA-precipitated protein pellets were with Tris-HCl pH 8.5 8 M urea, followed by addition of TCEP (Pierce) and chloroacetamide (Sigma) to a final concentration of 5 mM and 10 mM, respectively. Proteins were digested using Endoproteinase Lys-C (Roche) at 37oC overnight. The samples were brought to a final concentration of 2 M urea and 2 mM CaCl2 and a second digestion was performed overnight at 37oC using trypsin (Promega). Digested peptides were loaded on a split-triple-phase fused-silica micro-capillary column and placed in-line with a linear ion trap mass spectrometer (LTQ, Thermo Scientific), coupled with a Quaternary Agilent 1100 Series HPLC system. A fully automated 10-step chromatography run was carried out. Each full MS scan (400-1600 m/z) was followed by five data-dependent MS/MS scans. The number of the micro scans was set to 1 both for MS and MS/MS. The settings were as follows: repeat count 2; repeat duration 30 s; exclusion list size 500 and exclusion duration 120 s, while the minimum signal threshold was set to 100. MS Data Processing: The MS/MS data set was searched using ProLuCID (v. 1.3.3) against 36628 non-redundant Homo sapiens proteins (downloaded from NCBI RefSeq 2016-06-10), 193 usual contaminants, and, to estimate false discovery rates (FDRs), 36821 randomized amino acid sequences derived from each NR protein. To account for alkylation by CAM, 57 Da were added statically to the cysteines. To account for oxidation, 16 Da were added as a differential modification to methionines. Peptide/spectrum matches were sorted and selected to an FDR less than 5% at the peptide and protein levels, using DTASelect in combination with swallow, an in-house software.

INSTRUMENT(S): LTQ

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Laurence Florens  

PROVIDER: MSV000083364 | MassIVE | Fri Jan 25 12:41:00 GMT 2019

SECONDARY ACCESSION(S): PXD012516

REPOSITORIES: MassIVE

altmetric image

Publications

Merkel cell polyomavirus activates LSD1-mediated blockade of non-canonical BAF to regulate transformation and tumorigenesis.

Park Donglim Esther DE   Cheng Jingwei J   McGrath John P JP   Lim Matthew Y MY   Cushman Camille C   Swanson Selene K SK   Tillgren Michelle L ML   Paulo Joao A JA   Gokhale Prafulla C PC   Florens Laurence L   Washburn Michael P MP   Trojer Patrick P   DeCaprio James A JA  

Nature cell biology 20200413 5


Merkel cell carcinoma (MCC)-a neuroendocrine cancer of the skin-is caused by the integration of Merkel cell polyomavirus and persistent expression of large T antigen and small T antigen. We report that small T antigen in complex with MYCL and the EP400 complex activates the expression of LSD1 (KDM1A), RCOR2 and INSM1 to repress gene expression by the lineage transcription factor ATOH1. LSD1 inhibition reduces the growth of MCC in vitro and in vivo. Through a forward-genetics CRISPR-Cas9 screen,  ...[more]

Similar Datasets

2020-09-14 | PXD019239 | Pride
2020-03-20 | MSV000085125 | MassIVE
2019-12-10 | MSV000084671 | MassIVE
2018-06-28 | MSV000082521 | MassIVE
2005-04-07 | GSE2408 | GEO
2019-02-20 | MSV000083465 | MassIVE
2019-01-08 | MSV000083305 | MassIVE
2018-06-28 | MSV000082520 | MassIVE
2020-03-20 | MSV000085126 | MassIVE
2009-01-13 | GSE11810 | GEO